MLYS - CIK 0001933414
Mineralys Therapeutics, Inc. has filed 350 documents with the SEC between 2022 and 2026. The most frequent type is insider trade (143 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider sale notice | 144 | 2024-07-16 | - |
| Insider trade | 4 | 2024-07-12 | 2024-07-11 |
| Insider trade | 4 | 2024-07-12 | 2024-07-11 |
| Insider trade | 4 | 2024-07-12 | 2024-07-11 |
| Insider sale notice | 144 | 2024-07-11 | - |
| Insider sale notice | 144 | 2024-07-11 | - |
| Insider sale notice | 144 | 2024-06-20 | - |
| Insider trade | 4 | 2024-06-20 | 2024-06-17 |
| Insider sale notice | 144 | 2024-06-18 | - |
| Insider sale notice | 144 | 2024-06-17 | - |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| New insider ownership | 3 | 2024-06-17 | 2024-06-13 |
| Insider sale notice | 144 | 2024-06-14 | - |
| Insider trade | 4 | 2024-06-14 | 2024-06-12 |
| Major company event | 8-K | 2024-06-14 | 2024-06-13 |
| Insider sale notice | 144 | 2024-06-13 | - |
| Insider trade | 4 | 2024-06-13 | 2024-06-11 |
| Insider trade | 4 | 2024-06-13 | 2024-06-11 |
| Insider sale notice | 144 | 2024-06-12 | - |
| Insider sale notice | 144 | 2024-06-11 | - |
| Major company event | 8-K | 2024-06-10 | 2024-06-10 |
| Major company event | 8-K | 2024-05-31 | 2024-05-31 |
| Insider trade | 4 | 2024-05-28 | 2024-05-22 |
| Insider trade | 4 | 2024-05-23 | 2024-05-22 |
| Insider trade | 4 | 2024-05-23 | 2024-05-22 |
| Insider trade | 4 | 2024-05-23 | 2024-05-22 |
| Insider trade | 4 | 2024-05-23 | 2024-05-22 |
| Insider trade | 4 | 2024-05-23 | 2024-05-22 |
| Insider trade | 4 | 2024-05-23 | 2024-05-22 |
| Major company event | 8-K | 2024-05-22 | 2024-05-22 |
| Insider trade | 4 | 2024-05-15 | 2024-05-13 |
| Insider trade | 4 | 2024-05-10 | 2024-05-09 |
| Insider sale notice | 144 | 2024-05-09 | - |
| Quarterly report | 10-Q | 2024-05-09 | 2024-03-31 |
| Major company event | 8-K | 2024-05-09 | 2024-05-09 |
| Insider trade | 4 | 2024-04-15 | 2024-04-11 |
| EFFECT | - | 2024-04-11 | - |
| Prospectus supplement | 424B5 | 2024-04-11 | - |
| Annual report to shareholders | ARS | 2024-04-09 | 2023-12-31 |
| Proxy materials | DEFA14A | 2024-04-09 | - |
| Proxy statement | DEF 14A | 2024-04-09 | 2024-04-09 |
| Company correspondence | CORRESP | 2024-04-09 | - |
| Major company event | 8-K | 2024-04-04 | 2024-03-29 |
| S-3/A | - | 2024-03-29 | - |
| SEC correspondence | UPLOAD | 2024-03-26 | - |
| Major company event | 8-K | 2024-03-21 | 2024-03-21 |
| Securities registration | S-3 | 2024-03-21 | - |
| Annual report | 10-K | 2024-03-21 | 2023-12-31 |
| Insider trade | 4 | 2024-03-13 | 2024-03-11 |
| Insider trade | 4 | 2024-02-15 | 2024-02-13 |